<DOC>
	<DOCNO>NCT01621178</DOCNO>
	<brief_summary>The purpose study determine glycemic efficacy safety dulaglutide compare insulin glargine treatment participant type 2 diabetes moderate severe chronic kidney disease .</brief_summary>
	<brief_title>A Study Comparing Dulaglutide With Insulin Glargine Glycemic Control Participants With Type 2 Diabetes ( T2D ) Moderate Severe Chronic Kidney Disease ( CKD )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Dulaglutide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Immunoglobulin Fc Fragments</mesh_term>
	<criteria>Men nonpregnant woman age ≥18 year Hemoglobin A1c ( HbA1c ) ≥7.5 % ≤10.5 % Type 2 diabetes insulin insulin + oral antihyperglycemic medication Participants presume diabetic kidney disease without hypertensive nephrosclerosis diagnose moderate severe CKD estimate glomerular filtration rate ( eGFR ) ≥15 &lt; 60 milliliter per minute ( mL/min ) /1.73 meter square ( m^2 ) Able willing perform multiple daily injection Body mass index ( BMI ) 23 45 kilogram/square meter ( kg/m^2 ) Stage 5 CKD define eGFR &lt; 15 mL/min/1.73 m^2 OR require dialysis Rapidly progress renal dysfunction likely require renal replacement History transplant organ Type 1 diabetes mellitus At screen systolic blood pressure ≥150 mmHg diastolic blood pressure ≥90 mmHg without antihypertensive medication An episode ketoacidosis hyperosmolar state/coma past 6 month history severe hypoglycemia past 3 month prior Screening Visit Cardiovascular condition within 12 week prior randomization : acute myocardial infarction , New York Heart Association ( NYHA ) class III class IV heart failure , cerebrovascular accident ( stroke ) Acute chronic hepatitis Signs symptoms chronic acute pancreatitis , past diagnose pancreatitis Serum calcitonin ≥35 picograms per milliliter ( pg/mL ) Screening Visit Self family history medullary Ccell hyperplasia , focal hyperplasia , carcinoma Known history untreated proliferative retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>